Calendar

pharmadog

Week of Aug 14, 2023

Aug 14, 2023approval1094d agoAMJEVITA (ADALIMUMAB-ATTO) — FDA approvalAMJEVITA

Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION

full page →AMJEVITA →fda approvals ↗

Aug 15, 2023approval1093d agoVONJO (PACRITINIB CITRATE) — FDA approvalpacritinib

Sponsor: SOBI. Form: CAPSULE. Route: ORAL

full page →pacritinib →fda approvals ↗

Aug 16, 2023approval1092d agoABRILADA (ADALIMUMAB-AFZB) — FDA approvalABRILADA

Sponsor: PFIZER INC. Form: INJECTABLE. Route: INJECTION

full page →ABRILADA →fda approvals ↗

Aug 16, 2023approval1092d agoRIFADIN (RIFAMPIN) — FDA approvalRIFADIN

Sponsor: SANOFI AVENTIS US. Form: INJECTABLE. Route: INJECTION

full page →RIFADIN →fda approvals ↗

Aug 16, 2023approval1092d agoRIFATER (ISONIAZID) — FDA approvalRIFATER

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →RIFATER →fda approvals ↗

Aug 16, 2023approval1092d agoRIFADIN (RIFAMPIN) — FDA approvalRIFADIN

Sponsor: SANOFI AVENTIS US. Form: CAPSULE. Route: ORAL

full page →RIFADIN →fda approvals ↗

Aug 16, 2023approval1092d agoACETAZOLAMIDE — FDA approvalAccord Healthcare Inc

Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Aug 16, 2023approval1092d agoVOQUEZNA TRIPLE PAK (AMOXICILLIN) — FDA approvalamoxicillin + clarithromycin + vonoprazan

Sponsor: PHATHOM. Form: CAPSULE, TABLET, TABLET. Route: ORAL

full page →amoxicillin + clarithromycin + vonoprazan →fda approvals ↗

Aug 16, 2023approval1092d agoVOQUEZNA DUAL PAK (AMOXICILLIN) — FDA approvalamoxicillin + vonoprazan fumarate

Sponsor: PHATHOM. Form: CAPSULE, TABLET. Route: ORAL

full page →amoxicillin + vonoprazan fumarate →fda approvals ↗

Aug 17, 2023approval1091d agoVEKLURY (REMDESIVIR) — FDA approvalremdesivir

Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS

full page →remdesivir →fda approvals ↗

Aug 18, 2023approval1090d agoEYLEA HD (AFLIBERCEPT) — FDA approvalEYLEA HD

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

full page →EYLEA HD →fda approvals ↗

Aug 18, 2023approval1090d agoFLUOXETINE HYDROCHLORIDE — FDA approvalFLUOXETINE HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗

Week of Aug 21, 2023

Aug 22, 2023approval1086d agoFOCINVEZ (FOSAPREPITANT DIMEGLUMINE) — FDA approvalAthenex Inc (Inactive)

Sponsor: STERISCIENCE. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

Aug 23, 2023approval

Week of Aug 28, 2023

Aug 28, 2023approval1080d agoREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalluspatercept

Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS

full page →luspatercept →fda approvals ↗

Aug 29, 2023approval

Week of Sep 4, 2023

Sep 5, 2023approval1072d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Sep 5, 2023approval

Week of Sep 11, 2023

Sep 11, 2023approval1066d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Sep 11, 2023approval

← prev

page 8 of 501

Week of Aug 14, 2023

Week of Aug 21, 2023

Week of Aug 28, 2023

Week of Sep 4, 2023

Week of Sep 11, 2023